- Home
- GRVY vs OVID Comparison
GRVY vs OVID Comparison
Compare GRVY & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | OVID |
|---|---|---|
| Founded | 2000 | 2014 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.7M | 562.5M |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GRVY | OVID |
|---|---|---|
| Price | $67.40 | $2.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $6.02 |
| AVG Volume (30 Days) | 13.0K | ★ 1.4M |
| Earning Date | 11-06-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $7,252,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.05 | ★ N/A |
| Revenue Growth | N/A | ★ 1181.27 |
| 52 Week Low | $54.54 | $1.18 |
| 52 Week High | $76.00 | $3.11 |
Technical Indicators
Market Signals| Indicator | GRVY | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 42.32 | 36.09 |
| Support Level | $60.04 | $2.18 |
| Resistance Level | $71.94 | $2.38 |
| Average True Range (ATR) | 1.59 | 0.14 |
| MACD | -0.23 | -0.03 |
| Stochastic Oscillator | 27.27 | 13.04 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. The gaming products of the company include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation. Geographically, it derives maximum revenue from Taiwan.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.